Hep C Discussion Forum

Members Login
Username 
 
Password 
    Remember Me  
Chatbox
Please log in to join the chat!
Post Info TOPIC: HCV Advocate Monthly Report
Tig


Admin

Status: Offline
Posts: 8224
Date:
HCV Advocate Monthly Report
Permalink  
 


June 2018 Newsletter:

More†2018 Updates from the Intl. Liver Conference



__________________

Tig

62 yo GT1A - 5 Mil - A2/F3 - (1996) Intron A - Non Responder, (2013) Peg/Riba/Vic SOT:05/23/13 EOT:12/04/13 SVR 1-4 years!

Hep C FAQ† †Lab Ref. Ranges

Signature Line Set Up/Abbreviations† †Payment Assistance



Veteran Member

Status: Offline
Posts: 54
Date:
Permalink  
 

Tig wrote:

May 2018 HCV Advocate Updates

Interesting study data on the issue of progression of fibrosis and steatosis, secondary to cannabis and coffee use. Im sure there are some people interested in that!†

wink


†My best take away was:

Abstract:

THU-365 Salvage treatment of HCV patients by Sofosbuvir, Daclatasvir, Simeprevir and Ribavirin after repeated treatment failures is associated with SVR and reduced risk of hepatocellular carcinoma - A. Hanafy, et al.

Study† Aims† and† Results:

To† evaluate† sofosbuvir, daclatasvir, simeprevir plus ribavirin treatment for 12 weeks for people who had previously failed a course of direct-acting antiviral therapy compared to a similar group who received a placebo (sugar pill). The goal was† to† compare† the† reduced† risk† of† hepatocellular carcinoma (liver cancer) between† the† treated† and untreated group. The two groups (50 people treated; 50 people untreated) were evenly matched by age and gender.†

The two groups were followed for two years. The cure rate was 100% and the treatment was safe
and well tolerated.

Not only did this salvage therapy produce 100% cure rate, it also reduced the rate of liver cancer. This study demonstrates that we can cure everyone with hepatitis C if we can just put our minds, money, and drugs to the task.

However also browse this article which documented lower success rates for the sofosbuvir/daclatasvir/simeprevir/ribavirin combination therapy.



-- Edited by lamassu on Saturday 2nd of June 2018 01:46:35 PM



-- Edited by lamassu on Saturday 2nd of June 2018 01:48:37 PM

__________________

Male, 65, Dx 1990, GT 2a/2c. Pre-treatment VL 11,500,000, ALT 10, AST 18, Fibroscan F3, 12.4 kPa. Rx 12 weeks Epclusa, SOT Mar 8, 2018, EOT May 30, 2018. Week 2 VL 50, ALT 12, AST 21. Week 10 VL not detected, ALT 12, AST 18.

Tig


Admin

Status: Offline
Posts: 8224
Date:
Permalink  
 

We are continuing our conference coverage of the International Liver Congress 2018 and we have the following posters and presentations.

June 01, 2018 HCV Advocate EBlast

Thanks to HCVAdvocate.org†



__________________

Tig

62 yo GT1A - 5 Mil - A2/F3 - (1996) Intron A - Non Responder, (2013) Peg/Riba/Vic SOT:05/23/13 EOT:12/04/13 SVR 1-4 years!

Hep C FAQ† †Lab Ref. Ranges

Signature Line Set Up/Abbreviations† †Payment Assistance

Tig


Admin

Status: Offline
Posts: 8224
Date:
Permalink  
 

May 2018 HCV Advocate Updates

Interesting study data on the issue of progression of fibrosis and steatosis, secondary to cannabis and coffee use. Iím sure there are some people interested in that!†

wink



__________________

Tig

62 yo GT1A - 5 Mil - A2/F3 - (1996) Intron A - Non Responder, (2013) Peg/Riba/Vic SOT:05/23/13 EOT:12/04/13 SVR 1-4 years!

Hep C FAQ† †Lab Ref. Ranges

Signature Line Set Up/Abbreviations† †Payment Assistance



Guru

Status: Offline
Posts: 2626
Date:
Permalink  
 

Interesting Hep A info Tig! - I had only really been trying to follow the Calif. outbreak stats, quite interesting to see how many in Michigan as well! Maybe I'll re-post these newest stats over in Up-surge of Hep A in California†.

... In 2017 and early 2018, four states reported major outbreaks of hepatitis A (HAV) to the Centers for Disease Control and Prevention (CDC). The list below reflects the numbers provided by the CDC and news reports at the time this article went to print. California: As of December 29, 2017: 683 cases; 443 hospitalizations; 21 deaths. San Diego is the site of the largest outbreak. Michigan: As of January 10, 2018: 658 cases; 539 hospitalizations; 22 deaths. Utah: January 10, 2018: 152 cases; 68 hospitalizations; no deaths. Kentucky: Reported 44 cases of HAV, but no cases resulted in death. The majority of the HAV outbreaks were among the homeless population and people who inject or take drugs ...††



__________________

HCV/HBV 1973. HBV resolved. HCV undiagnosed to 2015. 63 y.o. F. Canada.

GT3a, Fibroscan F3/12 kPa - F4/12.6 kPa, VL log 7.01 (10,182,417), steatosis, high iron load.

SOF/VEL with/without GS-9857 trial - NCT02639338.

SOT March 10 - EOT May 5, 2016 - SOF/VEL/VOX 8 week trial.

(SEE UPDATES IN BIO)

Tig


Admin

Status: Offline
Posts: 8224
Date:
Permalink  
 

Another E-Blast HCV update. This has some interesting topics like the current Hep A outbreaks and meditation. We have discussed both recently.

HCV Advocate E-Blast 02/18



__________________

Tig

62 yo GT1A - 5 Mil - A2/F3 - (1996) Intron A - Non Responder, (2013) Peg/Riba/Vic SOT:05/23/13 EOT:12/04/13 SVR 1-4 years!

Hep C FAQ† †Lab Ref. Ranges

Signature Line Set Up/Abbreviations† †Payment Assistance

Tig


Admin

Status: Offline
Posts: 8224
Date:
Permalink  
 

The December 2017 HCV Advocate E Blast Newsletter. Reports on the recent Liver Meeting.

Dec 2017 EBlast



__________________

Tig

62 yo GT1A - 5 Mil - A2/F3 - (1996) Intron A - Non Responder, (2013) Peg/Riba/Vic SOT:05/23/13 EOT:12/04/13 SVR 1-4 years!

Hep C FAQ† †Lab Ref. Ranges

Signature Line Set Up/Abbreviations† †Payment Assistance

Tig


Admin

Status: Offline
Posts: 8224
Date:
Permalink  
 

Current reports from the HCV Advocate Drug Pipeline and Monthly report. Good stuff!

August 1, 2017

Aug 2017 Eblast Newsletter



__________________

Tig

62 yo GT1A - 5 Mil - A2/F3 - (1996) Intron A - Non Responder, (2013) Peg/Riba/Vic SOT:05/23/13 EOT:12/04/13 SVR 1-4 years!

Hep C FAQ† †Lab Ref. Ranges

Signature Line Set Up/Abbreviations† †Payment Assistance

Page 1 of 1  sorted by
 
Quick Reply

Please log in to post quick replies.

Legal Disclaimer:

THIS FORUM, IT'S OWNERS, ADMINISTRATORS, MODERATORS AND MEMBERS DO NOT AT ANY TIME GIVE MEDICAL ADVICE AND IN ALL CASES REFER ANYONE HERE TO SEEK APPROPRIATE MEDICAL ADVICE FROM THEIR DOCTOR.